News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Beverly Enterprises Responds To 13-D/A Filing
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FORT SMITH, Ark.--(BUSINESS WIRE)--Jan. 27, 2005--Beverly Enterprises, Inc. (NYSE: BEV) today issued the following letter in response to the 13-D/A Filing by the Formation Capital group:
Twitter
LinkedIn
Facebook
Email
Print